A good question makes the offer less fuzzy. Use these prompts before sharing payment details or agreeing to care.
A broad label is not enough. The ingredient name is the plain chemical name, such as semaglutide; the brand name, such as Wegovy, is the name on the box. Ask for the ingredient, the form, and whether the medicine is an FDA-approved product or a compounded one. The form means a pen, a vial, or a tablet. Compounded means a pharmacy mixed it to order.
A registered pharmacy or facility still turns out unapproved medicines: as of September 2026, nothing compounded carries FDA approval.
Source AThe prescriber is the person who writes your prescription. Ask for that person’s full name, and whether they are a medical doctor, a nurse practitioner, or another kind of licensed prescriber. Ask when you can speak with that person, not only a support desk.
State medical board policy, as of September 2026, requires the prescriber to hold permission to treat patients in whichever state you happen to be sitting in while the visit takes place.
Source BGet the pharmacy’s exact name before payment. That name turns a vague promise into a record you can check.
FDA cautions that someone getting care online may never learn which compounder (the pharmacy or business that mixed the medicine) actually made it.
Source CState medical boards keep public records showing if a doctor is licensed and if the board has ever acted against that doctor.
Source DFDA provides a hub that links to each state’s pharmacy licence search.
Source EAn online questionnaire with fixed questions can miss the one detail that changes the decision. Ask how the prescriber follows up when an answer needs more detail.
In May 2026, state medical boards said that picking a treatment from a list, with no real check by a doctor or nurse, is not proper care.
Source FThat guidance also expects patients to have some way of asking follow-up questions of their own.
Ask who answers after the first visit and what happens if a test, exam, or change in health needs attention.
Source FPut every possible charge into one clear frame.
Source A. FDA compounding questions and answers, plus the federal rule that separates registration from approval.
Source B. State medical boards’ telemedicine policy.
Source C. FDA advice on identifying a compounder.
Source D. State medical board consumer guide.
Source E. FDA state pharmacy directory.
Source F. State medical boards’ prescribing guidance.